The FDA has awarded its latest national priority voucher to Johnson & Johnson’s Tecvayli (teclistamab-cqyv) in combination with daratumumab for the treatment of relapsed or refractory multiple myeloma ...
LINKER-MM4 trial shows linvoseltamab monotherapy achieves a 79% overall response rate in newly diagnosed MM patients, with 92 ...
Altitude has released Chris Stuckmann’s chilling horror Shelby Oaks on DVD, Blu-ray and Digital. Starring Camille Sullivan, ...
A company named around “SEO” is now tethered to a term that no longer reflects the full breadth of modern discovery work.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback